Akumin Inc AKUMQ

There’s a ton of upside to Akumin (AKU), says Clarus

[davgro]

By Jayson MacLean 

Published on August 16, 2022

It’s a good time to be buying US healthcare stock Akumin Inc. (NASDAQ:AKU), according to Clarus Securities analyst Noel Atkinson. Akumin is down about 68 per cent over the past 12 months, but a new cash injection has Atkinson raising his target price on Monday from $6.50 to $6.75 per share, good for a projected return of 777 per cent at the time of publication.

Continue reading at link below:

https://www.cantechletter.com/2022/08/theres-a-ton-of-upside-to-akumin-says-clarus/

[willyk3]

Thanks for posting...we need all the good press we can get.  

[mjh9413]

I bought because I liked the idea the Alliance people were going to steer the Company but with Zine and Stonepeak  holding sway I am peeved. Zine gets a nice paycheck and other benefits while stonepeak reaps Millions$ in finance charges every qtr, the latter inflating the adj Ebitda number by 80%+. The latter wud have prevailed under any leadership but the existing group is just 'for the